August 14th 2025
With this expansion, BostonSight reinforces its commitment to advancing care for patients with severe ocular surface disease and irregular corneas.
AAOpt 2024: Managing neuropathic corneal pain
Erin Rueff, OD, PhD, FAAO, details the presentation she gave at this year's conference on the importance of validating patients' symptoms in cases of neuropathic corneal pain.
Brightstar Therapeutics appoints Jared Young as new chief commercial officer
September 6th 2024Young will be aiding in expanding real-world evidence programs to promotion the adoption of Brightstar’s BrightMEM corneal allograft for the treatment of limbal stem cell deficiency and persistent epithelial defects.
AOA 2024: Decoding early keratoconus: The new management paradigm
Drs Clark Chang and Tracy Lynn Schroeder Swartz give an overview of their Optometry's Meeting talk on detecting keratoconus early, providing tips for the proper technology to use and how to properly detect high-risk patients.